Previous research demonstrated that certain microRNAs, including miR-142-3p, repress HCC progression and increase apoptosis to inhibit HCC by decreasing the PIK3CG-mediated activation of the PI3K/AKT pathway [21]. Here, AKT1 is linked to hepatocellular carcinoma.